Johnson & Johnson

Washington State Reaches Nearly $150 Million Settlement With Johnson & Johnson Over Opioid Crisis
Johnson & Johnson’s Second Bankruptcy Attempt Fails—Why the Judge Ruled Against the Pharma Giant
Texas Attorney General Investigating Whether COVID-19 Vaccine Manufacturers Misled Public
FDA Strengthens Warning Over Severe Condition Linked to Johnson & Johnson’s COVID-19 Vaccine